What is LII's health score?

LENNOX INTERNATIONAL INC (LII) has a TradeApes health score of 69 out of 100, rated Healthy. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is LII's estimated fair value?

Based on our 5-year discounted cash flow model, LENNOX INTERNATIONAL INC's estimated fair value is $274.39 per share, representing a -46.1% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is LII undervalued or overvalued?

Our model currently rates LII as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for LII... Refresh in a moment for the full analysis.

LENNOX INTERNATIONAL INC (LII)

Technology Overvalued medium healthy

$509.15

Updated: 2026-06-05

TradeApes Score

Financial Strength

85 Strong

Operating Trend

60 Healthy

Relative Value

70 Healthy

Capital Allocation

55 Mixed

Risk

70 Healthy

Est. Fair Value $274.39

DCF Upside -46.1%

Sector Rank #233 of 7565

Key Findings

+ Historically cheap — EV/EBITDA in bottom 25% of its 5-year range

Unlock Full Report →

− Altman Z-Score in grey zone — uncertain financial stability

Unlock Full Report →

1 free score card remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.